newsfilter
← Latest News
PR Newswire·

ADAR1 Capital Management Issues Open Letter to Keros Therapeutics Stockholders

ADAR1 Capital Management, LLC (together with its affiliates, "ADAR1"), the largest stockholder of Keros Therapeutics (Nasdaq: KROS) ("Keros" or the...